柯力傳感(603662.SH):已給多家國內協作機器人、人形機器人客户送樣
格隆匯9月6日丨柯力傳感(603662.SH)在投資者互動平台表示,公司2024年半年度報吿已於2024年8月30日披露。在新產品研發方面,報吿期內公司重點突破機器人傳感器。六維力/力矩傳感器已完成人形機器人手腕、腳腕,工業臂、協作臂末端的產品系列開發,掌握了結構解耦、算法解耦、高速採樣通訊等技術要點,並已給多家國內協作機器人、人形機器人客户送樣。公司將繼續投入研發力量,向微型、高頻響應、MEMS硅基、力控算法集成等方向進行突破。觸覺傳感器已啟動與多家企業、院校的合作,同時以自研模式進行研發,目前尚處於研發驗證階段。具體經營情況請見公司半年度報吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.